Advertisement
Advertisement

GHRS

GHRS logo

GH Research PLC Ordinary Shares

21.42
USD
Sponsored
+0.41
+1.95%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

21.06

-0.36
-1.70%

GH Research PLC Ordinary Shares Profile

About

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is based in DUBLIN.

Info & Links

CEO

Velichka Valcheva

Headquarters

JOSHUA DAWSON HOUSE, DAWSON STREET
DUBLIN, L2 D02 RY95, IRELAND

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ghres.com

Auditor

PricewaterhouseCoopers

Share holders

--

Employees

73

GH Research PLC Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

1.44B

Enterprise Value

1.20B

Enterprise Value/EBITDA(ttm)

-19.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.39

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-16.30%

Return on Invested Capital(ttm)

-16.40%

Return on Assets(ttm)

-15.77%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-60.38M

Net Income Available to Common(ttm)

-48.26M

Diluted EPS(ttm)

-0.80

Share Statistics

Beta (5Y Monthly)

1.00

52-Week Change

98.33%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

62.03M

Dividend Yield

0.00%

Float4

36.23M

% Held by Insiders

41.60%

% Held by Institutions

56.90%

Balance Sheet

Total Cash(mrq)

280.71M

Total Cash Per Share(mrq)

4.53

Total Debt(mrq)

512.00K

Total Debt/Equity(mrq)

0.18%

Current Ratio(mrq)

34.13%

Quick Ratio(mrq)

34.13%

Book Value Per Share(mrq)

4.51

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.71

Free Cash Flow(ytd)

-43.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement